Journal article · 2026 · Open access

Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review

Nikita Mahadev Ghadage

International Journal of Therapeutic Innovation., 4(2), 12–15 · Published 28 April 2026 · DOI 10.55522/ijti.v4i2.0143

Read the free full textCite this paper

In brief

“Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review” is a 2026 journal article by Nikita Mahadev Ghadage, published in International Journal of Therapeutic Innovation.. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at International Journal of Therapeutic Innovation..

Citations
0
Authors
1

Abstract

Poor aqueous solubility continues to be a critical barrier in the development of effective oral drug delivery systems, particularly for compounds classified under BCS Class II and IV. Although these molecules possess strong therapeutic promise, their clinical performance is often compromised by inadequate dissolution, restricted gastrointestinal absorption, and extensive first-pass metabolism. Solid lipid nanoparticles (SLNs) have gained considerable attention as an advanced nanocarrier platform capable of overcoming these limitations by improving drug solubilization, stabilizing chemically sensitive molecules, enhancing membrane permeability, and enabling controlled or site-specific release. This review provides a comprehensive overview of the fundamental concepts underlying SLN technology, including formulation principles, key preparation methods, and current characterization techniques. In addition, recent therapeutic applications of SLNs for enhancing the bioavailability of poorly soluble drugs are critically examined. The discussion also addresses existing challenges such as stability issues, drug expulsion, and scale-up complexities, along with potential safety considerations. Emerging innovations—such as targeted SLN systems, hybrid lipid matrices, and the integration of artificial intelligence in formulation design—are highlighted as promising directions for future development. Overall, SLNs represent a biocompatible and versatile nanotechnology platform with substantial potential to improve the clinical translation of poorly water-soluble therapeutic agents.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ghadage, N. M. (2026). Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review. International Journal of Therapeutic Innovation., 4(2), 12–15. https://doi.org/10.55522/ijti.v4i2.0143

MLA 9

Ghadage, Nikita Mahadev. “Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review.” International Journal of Therapeutic Innovation., vol. 4, no. 2, 2026, pp. 12–15. https://doi.org/10.55522/ijti.v4i2.0143.

Chicago

Ghadage, Nikita Mahadev. 2026. “Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review.” International Journal of Therapeutic Innovation. 4 (2): 12–15. https://doi.org/10.55522/ijti.v4i2.0143.

Harvard

Ghadage, N. M. (2026) ‘Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review’, International Journal of Therapeutic Innovation., 4(2), pp. 12–15. doi:10.55522/ijti.v4i2.0143.

IEEE

N. M. Ghadage, “Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review,” International Journal of Therapeutic Innovation., vol. 4, no. 2, pp. 12–15, 2026, doi: 10.55522/ijti.v4i2.0143.

BibTeX

@article{ghadage2026solid,
  title     = {{Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review}},
  author    = {Ghadage, Nikita Mahadev},
  journal   = {International Journal of Therapeutic Innovation.},
  year      = {2026},
  volume    = {4},
  number    = {2},
  pages     = {12--15},
  doi       = {10.55522/ijti.v4i2.0143},
  url       = {https://doi.org/10.55522/ijti.v4i2.0143}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems

  • solid lipid nanoparticles
  • bioavailability enhancement
  • poorly water-soluble drugs
  • oral drug delivery
  • BCS Class II and IV drugs
  • nanocarriers
  • drug solubilization
  • gastrointestinal absorption

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Ghadage, N. M. (2026). Solid lipid nanoparticle-based approaches for improving the bioavailability of low-solubility drugs: a detailed review. International Journal of Therapeutic Innovation., 4(2), 12–15. https://doi.org/10.55522/ijti.v4i2.0143

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at International Journal of Therapeutic Innovation..

Who wrote this paper?

Nikita Mahadev Ghadage.

What is the DOI of this paper?

10.55522/ijti.v4i2.0143. The permanent link is https://doi.org/10.55522/ijti.v4i2.0143.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.